September 2022

Tyme Technologies Completes Merger With Syros Pharmaceuticals

United States - Massachusetts | United States - New Jersey

Tyme Technologies, Inc., a biotechnology company developing cancer metabolism-based therapies, completed its acquisition by merger with Syros Pharmaceuticals, Inc., a leader in the development of medicines that control the expression of genes. A cross-office, cross-practice team of Faegre Drinker attorneys supported Tyme in the transaction, which closed on September 16, 2022.

Read the full press release for more information on the deal.

Related Legal Services

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.